Guardant Health Inc
NASDAQ:GH
Guardant Health Inc
NASDAQ:GH
Price:
18.82 USD
-1.47%
Market Closed
Updated:
May 8, 2024
Guardant Health Inc
Cash from Financing Activities
|
Guardant Health Inc
Cash from Financing Activities Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Guardant Health Inc
NASDAQ:GH
|
Cash from Financing Activities
$477.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$575.3m
|
CAGR 3-Years
26%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-2%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
-$1.3B
|
CAGR 3-Years
55%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
0%
|
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$6.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Guardant Health Inc's Cash from Financing Activities?
Cash from Financing Activities
477.4m
USD
477.4m
USD
Based on the financial report for Dec 31, 2023, Guardant Health Inc's Cash from Financing Activities amounts to 477.4m USD.
What is Guardant Health Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
10%
10%
The average annual Cash from Financing Activities growth rates for Guardant Health Inc have been -30% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
